XH

Xiao H.

Co-founder & CEO at Clarix Imaging

Xiao H. is the Co-Founder and CEO of Clarix Imaging Corporation since May 2016, following a decade of academic experience at The University of Chicago, where positions included Research Assistant Professor, Post-doctoral Scholar, and Research Assistant. Expertise lies in designing algorithms and innovative hardware for medical imaging devices. Prior research experience includes a role as a Research Assistant at BC Cancer Research Center from 2004 to 2006. Xiao H. holds a PhD in Medical Physics from the University of Chicago (2006-2013), an MSc in Physics from The University of British Columbia (2004-2006), and a Bachelor's Degree in Physics from Tsinghua University (1999-2003).

Location

Chicago, United States

Links


Org chart


Teams


Offices


Clarix Imaging

Clarix Imaging brings unprecedented clarity to intraoperative breast cancer lumpectomy margin visualization with our true 3D (CT) VSI-360™ Volumetric Specimen Imaging System. This advanced imaging technology takes breast surgeons and radiologists on a Journey Through the Specimen™ with views of any tissue slice from multiple angles – with no obscuring of the margins. Clarix Imaging is the only company to commercially offer a CT breast specimen imaging system. A venture-backed private company founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers radiologists and surgeons unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room. VSI-360™ generates a true 3D image of the specimen in real-time, and its advanced software tools allow users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins. Partner with us on our journey to advance outcomes in surgical oncology through innovations in imaging.


Employees

11-50

Links